TITLE

Temporal trends in presentation for outpatient HIV medical care 2000-2010: implications for short-term mortality

AUTHOR(S)
Seal, Paula; Jackson, David; Chamot, Eric; Willig, James; Nevin, Christa; Allison, Jeroan; Raper, James; Kempf, Mirjam; Schumacher, Joseph; Saag, Michael; Mugavero, Michael; Seal, Paula S; Jackson, David A; Willig, James H; Nevin, Christa R; Allison, Jeroan J; Raper, James L; Kempf, Mirjam C; Schumacher, Joseph E; Saag, Michael S
PUB. DATE
July 2011
SOURCE
JGIM: Journal of General Internal Medicine;Jul2011, Vol. 26 Issue 7, p745
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Background: Many newly diagnosed patients present to outpatient care with advanced HIV infection. More timely HIV diagnosis and initiation of care has the potential to improve individual health outcomes and has public health implications.Objective: To assess temporal trends in late presentation for outpatient HIV medial care as measured by CD4 count <200 cells/mm(3) and the implications on short-term (1-year) mortality.Design: We conducted a cohort study nested in a prospective HIV clinical cohort including patients establishing initial outpatient HIV treatment between 2000-2010. Time series regression analysis evaluated temporal trends in late presentation for care measured by the proportion of patients with a CD4 count <200 cells/mm(3) or an opportunistic infection at enrollment, and also evaluated trends in short-term mortality.Participants: Patients establishing initial outpatient HIV treatment between 2000-2010 at an academic HIV clinic.Main Measures: The proportion of patients with a CD4 count <200 cells/mm(3) or an opportunistic infection at initial presentation and short-term (1-year) mortality following clinic enrollment.Key Results: Among 1121 patients, 41% had an initial CD4 count <200 cells/mm(3), 25% had an opportunistic infection and 2.4% died within 1-year of their initial visit. Time series regression analysis demonstrated significant reductions in late presentation for HIV care and decreases in short-term mortality with temporal improvement preceding updated CDC HIV testing recommendations.Conclusion: We observed a significant decline in the number of patients presenting for outpatient HIV care with advanced disease, particularly in 2006-2010. A significant trend in improved short-term survival among patients establishing HIV care was also observed, likely related to more timely presentation for outpatient care in more recent years.
ACCESSION #
61265338

 

Related Articles

  • Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy. Rizzardi, G. Paolo; Harari, Alexandre; Capiluppi, Brunella; Tambussi, Giuseppe; Ellefsen, Kim; Ciuffreda, Donatella; Champagne, Patrick; Bart, Pierre-Alexandre; Chave, Jean-Philippe; Lazzarin, Adriano; Pantaleo, Giuseppe // Journal of Clinical Investigation;3/1/2002, Vol. 109 Issue 5, p681 

    Primary HIV-1 infection causes extensive immune activation, during which CD4(+) T cell activation supports massive HIV-1 production. We tested the safety and the immune-modulating effects of combining cyclosporin A (CsA) treatment with highly active antiretroviral therapy (HAART) during primary...

  • Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. Turner, Barbara J.; Fleishman, John A.; Wenger, Neil; London, Andrew S.; Burnam, M. Audrey; Shapiro, Martin F.; Bing, Eric G.; Stein, Michael D.; Longshore, Douglas; Bozzette, Samuel A.; Turner, B J; Fleishman, J A; Wenger, N; London, A S; Burnam, M A; Shapiro, M F; Bing, E G; Stein, M D; Longshore, D; Bozzette, S A // JGIM: Journal of General Internal Medicine;Sep2001, Vol. 16 Issue 9, p625 

    Objective: To distinguish the effects of drug abuse, mental disorders, and problem drinking on antiretroviral therapy (ART) and highly active ART (HAART) use.Design: Prospective population-based probability sample of 2,267 (representing 213,308) HIV-infected persons in...

  • The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women. Reimers, Laura L.; Mehta, Supriya D.; Massad, L. Stewart; Burk, Robert D.; Xianhong Xie; Ravel, Jacques; Cohen, Mardge H.; Palefsky, Joel M.; Weber, Kathleen M.; Xiaonan Xue; Anastos, Kathryn; Minkoff, Howard; Atrio, Jessica; D'Souza, Gypsyamber; Qian Ye; Colie, Christine; Zolnik, Christine P.; Spear, Gregory T.; Strickler, Howard D.; Xie, Xianhong // Journal of Infectious Diseases;11/1/2016, Vol. 214 Issue 9, p1361 

    Background:  Bacterial vaginosis (BV) is characterized by low abundance of Lactobacillus species, high pH, and immune cell infiltration and has been associated with an increased risk of human papillomavirus (HPV) infection. We molecularly assessed the cervicovaginal microbiota...

  • Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe. Schomaker, Michael; Leroy, Valeriane; Wolfs, Tom; Technau, Karl-Günter; Renner, Lorna; Judd, Ali; Sawry, Shobna; Amorissani-Folquet, Madeleine; Noguera-Julian, Antoni; Tanser, Frank; Eboua, François; Navarro, Maria Luisa; Chimbetete, Cleophas; Amani-Bosse, Clarisse; Warszawski, Josiane; Phiri, Sam; N'Gbeche, Sylvie; Cox, Vivian; Koueta, Fla; Giddy, Janet // International Journal of Epidemiology;Apr2017, Vol. 46 Issue 2, p453 

    Background: There is limited knowledge about the optimal timing of antiretroviral treatment initiation in older children and adolescents.Methods: A total of 20 576 antiretroviral treatment (ART)-naïve patients, aged 1-16 years at enrolment, from 19 cohorts in...

  • Jail inmates and HIV care: provision of antiretroviral therapy and Pneumocystis carinii pneumonia prophylaxis. White, M. C.; Mehrotra, A.; Menendez, E.; Estes, M.; Goldenson, J.; Tulsky, J. P. // International Journal of STD & AIDS;Jun2001, Vol. 12 Issue 6, p380 

    The objective of this study was to examine prescription and acceptance of antiretroviral therapy (ART) and Pneumocystis carinii pneumonia (PCP) prophylaxis in jail and at release. A retrospective cross sectional design was used, by record review, of 77 inmates receiving HIV-related care in the...

  • Interleukin 2 treatment for HIV infection. Blankson, Joel; Siliciano, Robert F.; Blankson, J; Siliciano, R F // JAMA: Journal of the American Medical Association;7/12/2000, Vol. 284 Issue 2, p236 

    Editorial. Discusses the disadvantages associated with the use of highly active antiretroviral therapy (HAART) for the treatment of HIV. Challenges to the patient; Complexity and toxicity of the regimen; Rationale for the use of interleukin-2 in HIV-1 infection; Mention of two articles in this...

  • Adherence to combination antiretroviral therapies in HIV patients of low health literacy. Kalichman, Seth C.; Ramachandran, Bineetha; Catz, Sheryl; Kalichman, S C; Ramachandran, B; Catz, S // JGIM: Journal of General Internal Medicine;May1999, Vol. 14 Issue 5, p267 

    Objective: To test the significance of health literacy relative to other predictors of adherence to treatment for HIV and AIDS.Participants: Community sample of HIV-seropositive men (n = 138) and women (n = 44) currently taking a triple-drug combination of...

  • Projected survival gains from revising state laws requiring written opt-in consent for HIV testing. April, Michael D.; Chiosi, John J.; Paltiel, A. David; Sax, Paul E.; Walensky, Rochelle P. // JGIM: Journal of General Internal Medicine;Jun2011, Vol. 26 Issue 6, p661 

    Background: Although the Centers for Disease Control and Prevention recommends HIV testing in all settings unless patients refuse (opt-out consent), many state laws require written opt-in consent.Objective: To quantify potential survival gains from passing state laws...

  • Dyslipidaemia in HIV-infected patients: association with adherence to potent antiretroviral therapy. Vergis, Emanuel N.; Paterson, David L.; Wagener, Marilyn M.; Swindells, Susan; Singh, Nina; Vergis, E N; Paterson, D L; Wagener, M M; Swindells, S; Singh, N // International Journal of STD & AIDS;Jul2001, Vol. 12 Issue 7, p463 

    Metabolic complications are being increasingly recognized among HIV-infected patients treated with potent combination antiretroviral therapies. We sought to assess the association of dyslipidaemia with adherence to protease inhibitor (PI) therapy and with the markers of clinical response to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics